Clinical Practice Guidelines From the AABBJeffrey L. Carson, Aaron A.R. Tobian, Gordon Guyatt et al.|JAMA|2016Cited by 1.1k
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialDavid J. Kuter, Janet L. Nichol, J. Th. M. de Wolf et al.|The Lancet|2008Cited by 862
Evaluation of bleeding and thrombotic events during long‐term use of romiplostim in patients with chronic immune thrombocytopenia (ITP)Terry Gernsheimer, Janet L. Nichol, James N. George et al.|Journal of Thrombosis and Haemostasis|2010Cited by 100
Cumulative donor-specific antibody threshold predicts platelet transfusion response in HLA-alloimmunized patientsAaron Boothby, Sandhya R. Panch, Matthew Tanner et al.|Blood Advances|2024Cited by 9
Evaluation of AMG 531 Efficacy in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura (ITP) in a Randomized Placebo-Controlled Phase 3 Study.Terry Gernsheimer, Janet L. Nichol, Vinod Pullarkat et al.|Blood|2007Cited by 6